The use of non-human primates in biological and medical research: Evidence submitted by FRAME to the Academy of Medical Sciences/Medical Research Council/Royal Society/Wellcome Trust Working Group

Alternatives to Laboratory Animals

Volumn 33, Issue 5, 2005, Pages 519-527

  Bhogal, Nirmala ^a   Hudson, Michelle ^a   Balls, Michael ^a   Combes, Robert D ^a  

^a RUSSELL AND BURCH HOUSE   (United Kingdom)

Author keywords

Infection; Neuroscience; Non human primate; Regulatory testing; Research; Three Rs; Zero option

Indexed keywords

ANATOMY; ANIMAL USE; ANIMAL WELFARE; BIOLOGY; CONTROLLED STUDY; ETHICS; INFORMATION PROCESSING; MEDICAL RESEARCH; MEDICAL SOCIETY; NONHUMAN; PHYSIOLOGY; PRIMATE; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE;

ANIMALIA; PRIMATES;

EID: 27744512928     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290503300501     Document Type: Review

References (57)

1. Carlsson, H.E., Schapiro, S.J., Farah, I. & Hau, J. (2004). Use of primates in research: a global overview. American Journal of Primatology 63, 225-237.
2. Hagelin, J. (2005). The use of live apes in research in the twenty-first century. ATLA 33, 111-118.
3. CEC (2005). Report from the Commission to the Council and the European Parliament: Fourth Report on the Statistics on the Number of Animals Used for Experimental and Other Scientific Purposes in the Member States of the European Union. COM(2005) 7 final, 20 January 2005. 13pp. Brussels, Belgium: European Commission.
4. Balls, M. (1995). The use of non-human primates as laboratory animals in Europe: moving toward the zero option. ATLA 23, 284-286.
5. Watanabe, H., Fujiyama, A., Hattori, M., Taylor, T.D., Toyoda, A., Kuroki, Y., Noguchi, H., BenKahla, A., Lehrach, H., Sudbrak, R., Kube, M., Taenzer, S., Galgoczy, P., Platzer, M., Scharfe, M., Nordsiek, G., Blocker, H.B., Hellmann, I., Khaitovich, P., Paabo, S., Reinhardt, R., Zheng, H.J., Zhang, X.L., Zhu, G.F., Wang, B.F., Fu, G., Ren, S.X., Zhao, G.P., Chen, Z., Lee, Y.S., Cheong, J.E., Choi, S.H., Wu, K.M., Liu, T.T., Hsiao, K.J., Tsai, S.F., Kim, C.G., Oota, S., Kitano, T., Kohara, Y., Saitou, N., Park, H.S., Wang, S.Y., Yaspo, M.L. & Sakaki, Y. (2004). DNA sequence and comparative analysis of chimpanzee chromosome 22. Nature, London 429, 382-388.
6. Caceres, M., Lachuer, J., Zapala, M.A., Redmond, J.C., Kudo, L., Geschwind, D.H., Lockhart, D.J., Preuss, T.M. & Barlow, C. (2003). Elevated gene expression levels distinguish human from non-human primate brains. Proceedings of the National Academy of Sciences USA 100, 13030-13035.
7. Uddin, M., Wildman, D.E., Liu, G.Z., Xu, W.B., Johnson, R.M., Hof, P.R., Kapatos, G., Grossman, L.I. & Goodman, M. (2004). Sister grouping of chimpanzees and humans as revealed by genome-wide phylogenetic analysis of brain gene expression profiles. Proceedings of the National Academy of Sciences USA 101, 2957-2962.
8. Buxhoeveden, D. & Casanova, M. (2000). Comparative lateralisation patterns in the language area of human, chimpanzee, and rhesus monkey brains. Laterality 5, 315-330.
9. Gilad, Y., Wiebe, V., Przeworski, M., Lancet, D. & Pääbo, S. (2003). Loss of olfactory receptor genes coincides with the acquisition of full trichromatic vision in primates. Plos Biol 2 e5, DOI 10.1371/journal.pbiol. 0020005 (Accessed 09.09.05).
10. Dennis, J.C., Smith, T.D., Bhatnagar, K.P., Bonar, C.J., Burrows, A.M. & Morrison, E.E. (2004). Expression of neuron-specific markers by the vomeronasal neuroepithelium in six species of primates. Anatomical Record Part A - Discoveries in Molecular, Cellular and Evolutionary Biology 281A, 1190-1200.
11. Reynolds, P.D., Pittler, S.J. & Scammell, J.G. (1997). Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate. Journal of Clinical Endocrinology and Metabolism 82, 465-472.
12. Abbott, D.H., Foong, SC, Barnett, DK & Dumesic, DA. (2004). Nonhuman primates contribute unique understanding to anovulatory infertility in women. ILAR Journal 45, 116-131.
13. Platt, J.L. & Parker, W. (1995). Another step towards xenotransplantation Nature Medicine 1, 1248-50.
14. Sandrin, M.S., Fodor, W.L., Mouhtouris, E., Osman, N., Cohney, S., Rollins, S.A., Guilemtte, E.R., Setter, E., Squinto, S.P. & McKenzie, I.F.C. (1995). Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Medicine 1, 1261-7.
15. Anon. (1996). Animal-to-Human Transplants. The Ethics of Xenotransplantation. 168pp. London, UK: Nuffield Council on Bioethics.
16. Chan, W.S., Chong, K.Y., Martinovich, C., Simerly, C. & Schatten, G. (2001). Transgenic monkeys produced by retroviral gene transfer into mature oocytes. Science, New York 291, 309-312.
17. Mepham, T.B., Combes, R.D., Balls, M., Barbieri, O., Blokhuis, H.J., Costa, P., Crilly, R.E., de Cock Buning, T., Delpire, V.C., O'Hare, M.J., Houdebine, L.-M., van Kreijl, C.P., van der Meer, M., Reinhardt, C.A., Wolf, E. & van Zeller, A.-M. (1998). The report and recommendations of ECVAM Workshop 28: The use of transgenic animals in the European Union. ATLA 26, 21-43.
18. Anon. (2002). The Welfare of Non-human Primates used in Research. 135pp. Brussels, Belgium: European Commission.
19. Montagnon, B.J. & Vincent-Falquet, J.C. (1998). Experience with the Vero cell line. Developments in Biological Standardization 93, 119-123.
20. Anon. (2002). Recommendations for the production and control of poliomyelitis vaccine (oral). WHO Technical Report Series 904 40. Website http://www. who.int/biologicals/publications/trs/areas/vaccines/p olio/en/WHO_TRS_904_A1polio_oral.pdf (Accessed 09.09.05).
21. Rezapkin, G.V., Alexander, W., Dragunsky, E., Parker, M., Pomeroy, K., Asher, D.M. & Chumakov, K.M. (1998). Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine. Virology 245, 183-187.
22. Rezapkin, G.V., Fan, L.J., Asher, D.M., Fibi, M.R., Dragunsky, E.M. & Chumakov, K.M. (1999). Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. Virology 258, 152-160.
23. Anon. (2000). Vaccines and biomedicines. WHO Drug Information 14, 216.
24. Dragunsky, E., Nomura, T., Karpinski, K., Furesz, J., Wood, D.J., Perivikov, Y., Abe, S., Kurata, T., Vanloocke, O., Karganova, G., Taffs, R., Heath, A., Ivshina, A. & Levenbook, I. (2003). Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study. Bulletin of the World Health Organisation 81, 251-262.
25. Anon. (2003). Report of WHO Consultation on Needs and Opportunities for SARS Vaccine Research and Development. Website http://www.who.int/vaccine_ research/diseases/sars/events/2003/ll/en/report.pdf (Accessed 09.09.05).
26. Anon. (2004). International Workshop on Development of Vaccines for SARS and New Human Influenza Vaccines. Website http://www.who.int/vaccine_research/ diseases/sars/events/2004/03/en/summary_conclusions.pdf (Accessed 09.09.05).
27. Martina, B.E.E., Haagmans, B.L., Kuiken, T., Fouchier, R.A.M., Rimmelzwaan, G.F., van Amerongen, G., Peiris, J.S.M., Lim, W. & Osterhaus, A.D.M.E. (2003). SARS virus infection of cats and ferrets. Nature, London 425, 915.
28. Anon. (2004). Summary of the Technical Meeting on 'SARS Animal Models'. 9pp. Website http://www. who.int/vaccine_research/diseases/sars/events/2004/02/ en/sars_feb04_report.pdf (Accessed 09.09.05).
29. ter Meulen, J., Bakker, A.B.H., van den Brink, E.N., Weverling, G.J., Martina, B.E.E., Haagmans, B.L., Kuiken, T., de Kruif, J., Preiser, W., Spaan, W., Gelderblom, H.R., Goudsmit, J. & Osterhaus, A.D.M.E. (2004). Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. The Lancet 363, 2139-2141.
30. Czub, M., Weingartl, H., Czub, S., He, R.T. & Cao, J.X. (2005). Evaluation of modified vaccine virus Ankara based recombinant SARS vaccine in ferrets. Vaccine 23, 2273-2279.
31. Nath, B.M., Schumann, K.E. & Boyer, J.D. (2000). The chimpanzee and other non-human-primate models in hIV-1 vaccine research. Trends in Microbiology 8, 426-431.
32. Anon. (2000). 106th Congress Report - 106-494 Chimpanzee Health Improvement, Maintenance and Protection Act. Website http://Thomas.loc.gov/ cgibin/cpquery/T?&report=sr494&dbname=cp106& (Accessed 09.09.05).
33. Bende, S. & Johnston, M.I. (2000). Update: Search for an AIDS vaccine. AIDS Reader 10, 526-538.
34. Nabel, G.J. (2001). Challenges and opportunities for development of an AIDS vaccine. Nature Medicine 410, 1002-1007.
35. Langley, G. (2002). Phasing Out Primate Use in Belgian Laboratories. 85pp. Brussels, Belgium: GAIA.
36. Peters, B.S. (2000). HIV immunotherapeutic vaccines. Antiviral Chemistry and Chemotherapy 11, 311-320.
37. Zheng, L., Huang, X.L., Fan, Z., Borowski, L., Wilson, C.C. & Rinaldo, C.R. (1999). Delivery of liposome encapsulated HIV type 1 proteins to human dendritic cells for stimulation of HIV type 1- specific memory of cytotoxic T lymphocyte responses. AIDS Research and Human Retroviruses 15, 1011-1020.
38. Collins, KB., Patterson, B.K., Naus, G.J., Landers, D.V. & Gupta, P. (2000). Development of a new in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nature Medicine 6, 475-479.
39. Kawamura, T., Cohen, C.C., Borris, D.L., Aquilino, E.A., Glushakova, S., Margolis, L.B., Orenstein, J.M., Offord, R.E., Neurath, A.R. & Blauvelt, A. (2000). Candidate microbiocides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. Journal of Experimental Medicine 192, 1491-1500.
40. Schwartz, D.H. & Iyengar, S. (2001). Positron emission tomography of the immune response to infection and vaccination. Alternatives Today (Spring), 10-12.
41. Anon. (2004). Seventh Report of The Animal Welfare Advisory Committee, 11pp. Sevenoaks, Kent, UK: dstl.
42. Geisbert, T.W., Young, H.A., Jahrling, P.B., Davis, K.J., Larsen, T., Kagan, E. & Hensley, L.E. (2003). Pathogenesis of Ebola hemorrhagic fever in primate models - Evidence that haemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. American Journal of Pathology 163, 2371-2382.
43. Geisbert, T.W., Hensley, L.E., Jahrling, P.B., Larsen, T., Geisbert, J.B., Paragas, J., Young, H.A., Fredeking, T.M., Rote, W.E. & Vlasuk, G.P. (2003). Treatment of Ebola virus infection with a recombinant inhibitor of factor Vila/tissue factor: a study in rhesus monkeys. The Lancet 362, 1953-1958.
44. Phipps, A.J., Premanandan, C., Barnewall, R.E. & Lairmore, M.D. (2004). Rabbit and non-human primate models of toxin-targeting human anthrax vaccines. Microbiology and Molecular Biology Reviews 68, 617-629.
45. Monath, T.P., Caldwell, J.R., Mundt, W., Fusco, J., Johnson, C.S., Buller, M., Jian, L., Gardner, B., Downing, G., Blum, P.S., Kemp, T., Nichols, R. & Weltzin, R. (2004). ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) - a second-generation smallpox vaccine for biological defence. International Journal of Infectious Diseases 8, Suppl. 2, S31-S44.
46. Jahrling, P.B., Hensley, L.E., Martinez, M.J., LeDuc, J.W., Rubins, K.H., Relman, D.A. & Huggins, J.W. (2004). Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proceedings of the National Academy of Sciences USA 101, 15196-15200.
47. Anon. (2005). The Ethics of Research Involving Animals. 335pp. London, UK: Nuffield Council on Bioethics.
48. Smith, J.A. & Boyd, K.M. (Eds.). (2002). The Use of Non-Human Primates in Research and Testing. 61pp. Leicester, UK: British Psychological Society.
49. Anon. (2002). The Use of Primates Under the Animals (Scientific Procedures) Act (1986): Analysis of Current Trends with Particular Reference to Regulatory Toxicology. 39pp. London, UK: Home Office Animal Procedures Committee.
50. FRAME/CRAE. (1987). The Use of Non-human Primates as Laboratory Animals in Great Britain. 16pp. Nottingham, UK: FRAME.
51. Balls, M. (2000). Proponent's statement: Moving toward the zero option for the use of non-human primates as laboratory animals. In Progress in the Reduction, Refinement and Replacement of Animal Experimentation (Ed. M. Balls, A.-M. van Zeller & M. Halder), pp. 1587-1601. Amsterdam, The Netherlands: Elsevier Science B.V.
52. Bhogal, N., Grindon, C., Combes, R. & Balls, M. (2005). Toxicity testing: creating a revolution based on new technologies. Trends in Biotechnology 23, 299-307.
53. Anon. (2005). Yerkes Researchers to develop first transgenic non-human primate model for inherited neurodegenerative disease. Website http://www. yerkes.emory.edu/newsroom/neurodegenerativedisease.html (Accessed 09.09.05).
54. Li, W.-H. & Saunders, M.A. (2005). The chimpanzee and us. Nature, London 437, 50-51.
55. Hill, R.S. & Walsh, C.A. (2005). Molecular insights into human brain evolution. Nature, London 437, 64-67.
56. The Chimpanzee Sequencing and Analysis Consortium (2005). Initial sequence of the chimpanzee genome and comparison with the human genome. Nature, London 437, 69-87.
57. Vandeberg, J.L. & Zola, S.M. (2005). A unique biomedical resource at risk. Nature, London 437, 30-32.